Your browser doesn't support javascript.
St Oswald’s hospice ambulatory care service development
BMJ Supportive & Palliative Care ; 12(Suppl 2):A49, 2022.
Article in English | ProQuest Central | ID: covidwho-1874682
ABSTRACT
BackgroundFor patients with chronic, life limiting haematological conditions such as Myelodysplastic syndrome (MDS), regular transfusion for relief of symptoms of anaemia requires frequent attendance to acute hospital. Literature demonstrates MDS is associated with significant impairment and poor prognosis with critical palliative care needs.1 Opportunities to address these needs can be challenging in an acute environment.The Covid-19 pandemic led to a revision of services offered in St. Oswald’s Hospice Day Services with the development of a new Ambulatory Care service for patients requiring blood transfusion. This involves working with specialities to offer services to patients who would benefit from earlier palliative care support.MethodFollowing a successful pilot service we have continued to capture patient experience, patient need to access services available from palliative care MDT whilst working collaboratively with Haematology and Oncology services.Records were kept of MDT services accessed alongside collated patient feedback.ResultsFrom March to October 2021 there have been 13 patients with 86 attendances for blood transfusionAll patients had initial assessment with a senior palliative medicine Doctor5 patients have engaged in Advance Care Planning discussions3 patients reviewed by Physiotherapy6 patients received complementary therapy1 patient reviewed by social worker5 patients had medical review for specific symptom management1 patient assessed by lymphoedema specialist2 patients referred to music therapist1 patient admitted to the inpatient unit for observation overnight1 patient admitted for end of life care after outpatient attendanceFeedback has been very positive from patients and their familiesConclusionPatient feedback has been very positive with patients accessing palliative care services and engaging in ACP. Increasing the number of referrals to the service will continue to widen access to patients not typically referred until later in their disease process, promoting improved quality of life and Advance Care Planning.ReferenceNickolich M, El-Jawahri A, LeBlanc TW. Palliative and end-of-life care in myelodysplastic syndromes. Curr Hematol Malig Rep 2016;11434–440.
Keywords

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: BMJ Supportive & Palliative Care Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: BMJ Supportive & Palliative Care Year: 2022 Document Type: Article